Molecular analysis of pericardial fluid: a 7-year experience.

AIMS Aetiological investigations of pericardial effusion are often negative. We evaluate the interest of systematic analysis of fluid in order to diminish the number of pericarditis classified as idiopathic. METHODS AND RESULTS We performed a systematic analysis of pericardial fluid and biopsy specimens, using cultures and molecular analyses for the identification of bacteriological, fungal, and viral agents, as well as histopathological examination of 106 pericardial fluid samples. The aetiological diagnosis was determined clinically and by non-invasive procedures in 40 and nine patients, respectively. In the remaining 57 patients, 14 neoplasias and 17 infections were diagnosed. Molecular procedures identified seven viral (Enterovirus, Herpes simplex virus, and Epstein-Barr virus in four, two, and one of the cases, respectively), one fungal (Cryptococcus neoformans), and nine bacterial infections. Four of these bacteria were not diagnosed by culture because of prior antibiotics treatment (Mycobacterium tuberculosis in two cases, Streptococcus pneumoniae in one case, and Actinomyces neuii in one case). The aetiology remained undetermined in 26 patients. CONCLUSION The systematic use of molecular techniques permitted a significant increase in aetiological diagnoses of punctured pericardial effusions when compared with cultures (39.5 vs. 13.9%, respectively; P<0.01). It is particularly beneficial for patients with a previous antibiotic regimen or suspicion of tuberculosis.

[1]  D. Raoult,et al.  Comparison of intuitive versus systematic strategies for aetiological diagnosis of pericardial effusion , 2005, Scandinavian journal of infectious diseases.

[2]  D. Raoult,et al.  Diagnosis of infectious endocarditis in patients undergoing valve surgery. , 2005, The American journal of medicine.

[3]  D. Raoult,et al.  PCR Detection of Bacteria on Cardiac Valves of Patients with Treated Bacterial Endocarditis , 2005, Journal of Clinical Microbiology.

[4]  L. Hillis,et al.  Clinical practice. Acute pericarditis. , 2004, The New England journal of medicine.

[5]  Raimund Erbel,et al.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. , 2004, European heart journal.

[6]  D. Raoult,et al.  Etiologic Diagnosis of 204 Pericardial Effusions , 2003, Medicine.

[7]  K. Klingel,et al.  Parvovirus B19 Infection Mimicking Acute Myocardial Infarction , 2003, Circulation.

[8]  A. Ristic,et al.  Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. , 2002, European heart journal.

[9]  A. Ristic,et al.  Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. , 2002, European heart journal.

[10]  J. Moore,et al.  Risk Assessment Models and Contamination Management: Implications for Broad-Range Ribosomal DNA PCR as a Diagnostic Tool in Medical Bacteriology , 2002, Journal of Clinical Microbiology.

[11]  D. Raoult,et al.  Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells , 1990, Journal of clinical microbiology.

[12]  R. C. Pruneda,et al.  Centrifugation-shell vial technique for rapid detection of herpes simplex virus cytopathic effect in Vero cells , 1987, Journal of clinical microbiology.

[13]  J. Soler‐Soler,et al.  Primary acute pericardial disease: a prospective series of 231 consecutive patients. , 1985, The American journal of cardiology.

[14]  R. J. Marvel Acute pericarditis. , 1956, The Journal of the Indiana State Medical Association.